FDA Inspection 1198233 — Donald M Brandon MD

Donald M Brandon MD — FEI 3005191563

The FDA completed an inspection of Donald M Brandon MD on February 24, 2023 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate